Indian Pharmaceuticals Sector – Key Trends and Outlook
--By Mr. Gaurav Jain,Ms. Kinjal Shah,Mr. Subrata Ray

Impact of NIP on the Construction Companies
--By Mr. Shubham Jain,Mr. Abhishek Gupta

Biosimilars Opportunity for Indian Pharmaceutical Sector
--By Mr. Subrata Ray,Mr. Gaurav Jain,Ms. Kinjal Shah

Revenue receipts of states governments to trail budgeted level in FY2020
--By Ms. Neetika Shridhar,Ms. Aditi Nayar,Mr. Jayanta Roy